LITTLE ROCK, Ark., March 02, 2017 -- Uniti Group Inc. (“Uniti”) (Nasdaq:UNIT) announced today that its Executive Vice President, Chief Financial Officer and Treasurer, Mark A. Wallace and Vice President Finance and Investor Relations, Jim Volk, are scheduled to present at Raymond James 38th Annual Institutional Investors Conference. The presentation is scheduled for 2:05 PM ET/ 1:05 PM CT on March 7, 2017 in Orlando, Florida.
You may access a live webcast of the event on Uniti’s website at www.uniti.com under the Investors tab. The webcast will be available for replay for a limited time on Uniti’s website following the presentation.
ABOUT UNITI
Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of wireless infrastructure solutions for the communications industry. Uniti owns 4.2 million fiber strand miles, 468 wireless towers, and other communications real estate throughout the United States and Latin America as of January 31, 2017. Additional information about Uniti can be found on its website at www.uniti.com.
INVESTOR CONTACT: Mark A. Wallace, 501-850-0866 EVP, Chief Financial Officer & Treasurer [email protected] Jim Volk, 501-850-0872 VP, Finance & Investor Relations [email protected]


Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



